3:19 PM
 | 
Oct 11, 2018
 |  BC Innovations  |  Translation in Brief

Public funding highlights: 3Q18

Public funding highlights: 3Q18

Selected developments and initiatives in 3Q18 from major sources of public funding including NIH, the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of Health Research (CIHR) and Singapore’s Agency for Science Technology and Research (A*STAR).

DateAgencySummaryType
July 3A*STARA*STAR’s Institute of Molecular and Cell Biology partnered with Indivumed GmbH to characterize the company's cancer biobank, adding proteomic and phosphoproteomic data to the databaseDeals
July 16NIHFindings by researchers at NIH's National Institute of General Medical Sciences (NIGMS) show that women maintain NIH funding at the same rate as men after receiving their first major grants, suggesting efforts to improve underrepresentation should be focused on encouraging women to enter biomedical sciences and preventing attrition at earlier career stagesGrants
July 18IMIIMI's latest calls for proposals include €434 million ($489.7 million) for an Antimicrobial...

Read the full 812 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$100 USD
More Info >